Optimizing Platelet Inhibition in Clopidogrel Poor Metabolizers
Author:
Funder
Bristol-Myers Squibb
Sanofi-Aventis
GlaxoSmithKline
Otsuka
Boston Scientific
Eli Lilly Co.
Daiichi Sankyo, Inc.
Medicines Company
Portola
Accumetrics
Schering-Plough
AstraZeneca
Eisai
Johnson & Johnson
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference25 articles.
1. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate;Bonello;J Am Coll Cardiol,2010
2. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives;Angiolillo;J Am Coll Cardiol,2007
3. Pharmacogenetics in cardiovascular antithrombotic therapy;Marín;J Am Coll Cardiol,2009
4. ACCF/AHA clopidogrel clinical alert: approaches to the FDA “boxed warning: ” a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association;Holmes;J Am Coll Cardiol,2010
5. High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2);Collet;J Am Coll Cardiol Intv,2011
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An Overview of Thrombin Inhibitors in the Perspective of Structureactivity Relationships;Current Medicinal Chemistry;2023-08
2. The Sodium–Glucose Co-Transporter-2 (SGLT2) Inhibitors Reduce Platelet Activation and Thrombus Formation by Lowering NOX2-Related Oxidative Stress: A Pilot Study;Antioxidants;2022-09-22
3. Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease;Frontiers in Pharmacology;2021-05-12
4. No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy;Journal of Clinical Medicine;2020-05-18
5. A brief review on resistance to P2Y12 receptor antagonism in coronary artery disease;Thrombosis Journal;2019-05-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3